News

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...
Kathleen Smith, 40, dropped three sizes on Mounjaro but says it wasn't 'worth it' after she lost her hair and it left her ...
We recently published a list of Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks.
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...
Eli Lilly said it plans to submit the pill to the Food and Drug Administration for approval as a weight loss medication this ...
Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...
While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...
Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss ...
The president of Omada Health talks about why decision makers need to be thinking about holistic weight-management care as ...
A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by the Trump administration. Here are five things to know: ...
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...